Article
Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein
Season 2, Episode 21: A Century of X-Rays with Margaret Yu
In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care.
Dr. Yu unpacks the 130-year history of radiation in medicine — from the discoveries of Marie and Pierre Curie to the approval of modern alpha isotopes — and explains how ARTBIO is developing new radioisotope-linked therapies to transform precision oncology.
She also shares deeply personal stories from her medical training, lessons from mentorship, and how being a “language brain in a science-driven world” shapes her communication and leadership approach. In the closing moments, Dr. Yu offers invaluable leadership advice on resilience, growth, and embracing challenges for anyone navigating their first leadership role in Pharma or biotech.
Whether you’re a Pharma executive, biotech innovator, or medical professional, this conversation delivers both inspiration and insight into the future of cancer treatment and scientific leadership.
Related Topics
You May Also Like
Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein
Press Release
OVN Staff
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
Press Release
OVN Staff
Introducing OncologyVoiceNetwork.com
Article
A. Haslam, M.S. Kim, V. Prasad
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
The Ideal Roadmap for New MSLs
Article
B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.